Ayala Pharmaceuticals
Advaxis Logo
Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.
About Advaxis
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. Its lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first-line treatment in unfit acute myeloid leukemia. The company operates in the United States and Israel and is based in Wilmington, Delaware.
Address
1007 North Orange Street, 4th Floor
Wilmington, 19802
United States
Year founded
2002
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Add Ayala Pharmaceuticals logo and brand data to your app or website
Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.
<img src="https://img.logokit.com/ayalapharma.com" />
Report inaccurate data
Request an update to help us keep the brand up-to-date.
